Washington, D.C, District of Columbia Aug 3, 2026 (Issuewire.com) - Fady Hannah-Shmouni, MD, FRCPC, is redefining the future of endocrine care by integrating clinical excellence, biomedical research, and artificial intelligence to advance precision medicine. As a board-certified clinical endocrinologist, biochemical geneticist, physician-scientist, and entrepreneur, Dr. Hannah-Shmouni is dedicated to improving patient outcomes through innovative technologies that support evidence-based, personalized healthcare.
As the Founder and Chief Executive Officer of Hormonaly.ai, Dr. Hannah-Shmouni leads the development of an advanced clinical artificial intelligence platform designed to assist physicians in making data-driven decisions in endocrinology, hormone optimization, and longevity medicine. By combining cutting-edge AI with established clinical guidelines, the platform aims to enhance diagnostic accuracy, improve treatment planning, and expand access to precision medicine on a global scale.
Dr. Hannah-Shmouni’s distinguished medical career reflects an unwavering commitment to excellence in both patient care and scientific discovery. He earned his medical degree from the University of Jordan School of Medicine in 2009 before completing his residency in Internal Medicine at Yale School of Medicine. He subsequently pursued fellowship training in Endocrinology and Metabolism at the National Institutes of Health, followed by a fellowship in Clinical Biochemical Genetics at the University of Toronto. He is dual board-certified in Internal Medicine and Endocrinology by both the United States and Canadian certifying boards.
Throughout his academic career, Dr. Hannah-Shmouni has held leadership positions that have shaped education and research in precision medicine. He previously served as Assistant Clinical Professor at the University of British Columbia and as Director of the AI Academy at the Geneva College of Longevity Science, where he educated clinicians on the growing role of artificial intelligence in modern healthcare. His clinical expertise spans stress physiology, metabolic disease, rare endocrine disorders, biochemical genetics, and hormone regulation.
An accomplished researcher, Dr. Hannah-Shmouni has authored more than 100 peer-reviewed scientific publications and has participated extensively in NIH-funded research. With an h-index of 28, his scholarly contributions have advanced the understanding of endocrinology, biochemical genetics, and cardiovascular endocrine disorders. He has also written multiple books and continues to contribute to the scientific literature, shaping clinical practice worldwide.
Beyond medicine and research, Dr. Hannah-Shmouni is an active entrepreneur and physician-investor who has founded and advised several health technology companies, including DrVibe.ai, Healthspan Digital, and ventures within the FHS Capital portfolio. Through these initiatives, he is helping bridge the gap between medicine and technology by developing intelligent clinical tools that support physicians while improving patient access to high-quality, evidence-based care.
Driven by a vision of more personalized, proactive healthcare, Dr. Hannah-Shmouni continues to lead innovations that harness artificial intelligence to transform endocrinology and longevity medicine. His multidisciplinary expertise and commitment to advancing precision medicine position him as a leading voice in the future of hormone health and digital healthcare innovation.
Learn more about Dr. Fady Hannah-Shmouni:
Visit his America’s Best in Medicine profile, https://americasbestinmedicine.com/connect/fady-hannah-shmouni, or his website, https://shmouni.com/
About America’s Best in Medicine
America’s Best in Medicine is a specialized online platform dedicated to amplifying the voices of leading healthcare professionals across the United States. It brings together top healthcare providers from all specialties and regions to share expert-driven articles, research, commentary, and clinical insight. Its core purposes are to showcase excellence in healthcare, build trust between providers and the public, and ensure that expert voices are elevated and heard in shaping medicine. Through its platform, users can access a community of leaders, opportunities for providers to share expertise, and trusted guidance for patients and peers alike.
Media Contact
America's Best in Medicine *****@americasbestinmedicine.com 1-877-346-0175 https://americasbestinmedicine.com
